Company Filing History:
Years Active: 2025
Title: Innovations of Kate Atkin in Binding Molecules
Introduction
Kate Atkin is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. Her work focuses on creating innovative solutions for the treatment of malignant diseases.
Latest Patents
Kate Atkin holds 1 patent related to binding molecules. This invention involves binding molecules that comprise T cell receptor (TCR) variable domains, which can bind to a PIWIL1 peptide-HLA complex. The implications of this invention are profound, as it relates to potential treatments for various malignant diseases.
Career Highlights
Atkin is currently associated with Immunocore Limited, a company known for its cutting-edge research in immunotherapy. Her role at Immunocore has allowed her to further her research and contribute to advancements in the field.
Collaborations
Throughout her career, Kate has collaborated with notable colleagues, including Nicole Mai and Arnaud Techine. These collaborations have enriched her work and expanded the impact of her inventions.
Conclusion
Kate Atkin's innovative work in binding molecules showcases her dedication to advancing medical science. Her contributions have the potential to significantly improve treatment options for patients with malignant diseases.